Erythropoietin: novelties in antidoping research

Wolfgang Jelkmann

doi:10.1016/j.coemr.2019.05.005

Erythropoietin: novelties in antidoping research

Wolfgang Jelkmann^*

^*Corresponding author for this work

Institute of Physiology

3 Citations (Scopus)

Abstract

This review focuses on discoveries regarding doping with recombinant human erythropoietin and other erythropoiesis-stimulating agents (ESAs), reported since 2017. While ESAs are known to increase the total mass of hemoglobin (Hb_mass), V˙O_2max and maximal power output unresolved questions have remained with respect to their effects on endurance performance. ESAs are detectable by electrophoresis or isoelectric focusing and immunoblotting of urine (or blood) samples. The methods have undergone some improvements. Novel erythropoietic substances will become available in the near future. Analytical methods are already available for the detection of Epo mimetic peptides, hypoxia-inducible factor stabilizers, and activin type II receptor ligand traps. The ‘athlete biological passport’ is an indirect instrument in antidoping efforts. Additional hematologic parameters such as hepcidin and erythroferrone may strengthen the athlete biological passport approach.

Original language	English
Journal	Current Opinion in Endocrine and Metabolic Research
Volume	9
Pages (from-to)	28-33
Number of pages	6
DOIs	https://doi.org/10.1016/j.coemr.2019.05.005
Publication status	Published - 12.2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Access to Document

10.1016/j.coemr.2019.05.005

Cite this

@article{0a6b1b204b664ae4a5b32cdde8ac7997,

title = "Erythropoietin: novelties in antidoping research",

abstract = "This review focuses on discoveries regarding doping with recombinant human erythropoietin and other erythropoiesis-stimulating agents (ESAs), reported since 2017. While ESAs are known to increase the total mass of hemoglobin (Hbmass), V˙O2max and maximal power output unresolved questions have remained with respect to their effects on endurance performance. ESAs are detectable by electrophoresis or isoelectric focusing and immunoblotting of urine (or blood) samples. The methods have undergone some improvements. Novel erythropoietic substances will become available in the near future. Analytical methods are already available for the detection of Epo mimetic peptides, hypoxia-inducible factor stabilizers, and activin type II receptor ligand traps. The {\textquoteleft}athlete biological passport{\textquoteright} is an indirect instrument in antidoping efforts. Additional hematologic parameters such as hepcidin and erythroferrone may strengthen the athlete biological passport approach.",

author = "Wolfgang Jelkmann",

year = "2019",

month = dec,

doi = "10.1016/j.coemr.2019.05.005",

language = "English",

volume = "9",

pages = "28--33",

journal = "Current Opinion in Endocrine and Metabolic Research",

issn = "2451-9650",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Erythropoietin: novelties in antidoping research

AU - Jelkmann, Wolfgang

PY - 2019/12

Y1 - 2019/12

N2 - This review focuses on discoveries regarding doping with recombinant human erythropoietin and other erythropoiesis-stimulating agents (ESAs), reported since 2017. While ESAs are known to increase the total mass of hemoglobin (Hbmass), V˙O2max and maximal power output unresolved questions have remained with respect to their effects on endurance performance. ESAs are detectable by electrophoresis or isoelectric focusing and immunoblotting of urine (or blood) samples. The methods have undergone some improvements. Novel erythropoietic substances will become available in the near future. Analytical methods are already available for the detection of Epo mimetic peptides, hypoxia-inducible factor stabilizers, and activin type II receptor ligand traps. The ‘athlete biological passport’ is an indirect instrument in antidoping efforts. Additional hematologic parameters such as hepcidin and erythroferrone may strengthen the athlete biological passport approach.

AB - This review focuses on discoveries regarding doping with recombinant human erythropoietin and other erythropoiesis-stimulating agents (ESAs), reported since 2017. While ESAs are known to increase the total mass of hemoglobin (Hbmass), V˙O2max and maximal power output unresolved questions have remained with respect to their effects on endurance performance. ESAs are detectable by electrophoresis or isoelectric focusing and immunoblotting of urine (or blood) samples. The methods have undergone some improvements. Novel erythropoietic substances will become available in the near future. Analytical methods are already available for the detection of Epo mimetic peptides, hypoxia-inducible factor stabilizers, and activin type II receptor ligand traps. The ‘athlete biological passport’ is an indirect instrument in antidoping efforts. Additional hematologic parameters such as hepcidin and erythroferrone may strengthen the athlete biological passport approach.

UR - https://www.scopus.com/pages/publications/85068187617

U2 - 10.1016/j.coemr.2019.05.005

DO - 10.1016/j.coemr.2019.05.005

M3 - Scientific review articles

AN - SCOPUS:85068187617

SN - 2451-9650

VL - 9

SP - 28

EP - 33

JO - Current Opinion in Endocrine and Metabolic Research

JF - Current Opinion in Endocrine and Metabolic Research

ER -

Erythropoietin: novelties in antidoping research

Abstract

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Fingerprint

Cite this